Aurinia Pharmaceuticals Inc. Shares Outstanding
Aurinia Pharmaceuticals Inc. (AUPH) had Shares Outstanding of 132.91 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 132.91M shares; Shares authorized (split-adjusted) (m).
- 2026-03-31: Shares outstanding (split-adjusted) 130.77M shares; Shares authorized (split-adjusted) (m).
- 2025-12-31: Shares outstanding (split-adjusted) 132.32M shares; Shares authorized (split-adjusted) (m).
- 2025-09-30: Shares outstanding (split-adjusted) 131.84M shares; Shares authorized (split-adjusted) (m).
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 132.91M shares 10-Q · filed 2026-08-06 | (m) |
| 2026-03-31 | 130.77M shares 10-Q · filed 2026-05-07 | (m) |
| 2025-12-31 | 132.32M shares 10-Q · filed 2026-08-06 | (m) |
| 2025-09-30 | 131.84M shares 10-Q · filed 2025-11-04 | (m) |
| 2025-06-30 | 132.67M shares 10-Q · filed 2025-07-31 | (m) |
| 2025-03-31 | 137.75M shares 10-Q · filed 2025-05-12 | (m) |
| 2024-12-31 | 140.88M shares 10-K · filed 2026-02-26 | (m) |
| 2024-09-30 | 143.11M shares 10-Q · filed 2024-11-07 | (m) |
| 2024-06-30 | 142.98M shares 10-Q · filed 2024-08-01 | (m) |
| 2024-03-31 | 143.69M shares 10-Q · filed 2024-05-02 | (m) |
| 2023-12-31 | 143.83M shares 10-K · filed 2025-02-27 | (m) |
| 2023-09-30 | 143.60M shares 10-Q · filed 2023-11-02 | (m) |
| 2023-06-30 | 143.37M shares 10-Q · filed 2023-08-03 | (m) |
| 2023-03-31 | 143.03M shares 10-Q · filed 2023-05-04 | (m) |
| 2022-12-31 | 142.27M shares 10-K · filed 2024-02-15 | (m) |
| 2022-09-30 | 142.11M shares 10-Q · filed 2022-11-03 | (m) |
| 2022-06-30 | 141.89M shares 10-Q · filed 2022-08-04 | (m) |
| 2022-03-31 | 141.74M shares 10-Q · filed 2022-05-10 | (m) |
| 2021-12-31 | 141.60M shares 10-K · filed 2024-02-15 | (m) |
| 2021-09-30 | 129.57M shares 10-Q · filed 2021-11-03 | (m) |
| 2021-06-30 | 128.40M shares 10-Q · filed 2021-08-05 | (m) |
| 2021-03-31 | 128.12M shares 10-Q · filed 2021-05-06 | (m) |
| 2020-12-31 | 126.70M shares 10-K · filed 2023-02-28 | (m) |
| 2019-12-31 | 111.80M shares 10-K · filed 2022-02-28 | (m) |
| 2018-12-31 | 85.50M shares 10-K · filed 2021-02-24 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |